- Previous Close
0.0000 - Open
0.1500 - Bid --
- Ask --
- Day's Range
0.1500 - 0.1500 - 52 Week Range
0.0738 - 0.1500 - Volume
325 - Avg. Volume
0 - Market Cap (intraday)
19.334M - Beta (5Y Monthly) 2.76
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2300 - Earnings Date May 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
www.immunovia.com9
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: IMMVF
View MorePerformance Overview: IMMVF
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IMMVF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IMMVF
View MoreValuation Measures
Market Cap
6.93M
Enterprise Value
4.46M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-104.55%
Return on Equity (ttm)
-194.66%
Revenue (ttm)
931k
Net Income Avi to Common (ttm)
-76.54M
Diluted EPS (ttm)
-0.2300
Balance Sheet and Cash Flow
Total Cash (mrq)
25.32M
Total Debt/Equity (mrq)
5.84%
Levered Free Cash Flow (ttm)
-62.85M